Home › Funds › Caligan Partners LP › ANIK

Caligan Partners LP position in ANIK

ANIKA THERAPEUTICS INC · Health Care

Caligan Partners LP reported holding 1,435,130 shares of ANIK (ANIKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.0M, representing 1.23% of its reported portfolio and ranking #18 among its reported holdings. Caligan Partners LP has disclosed ANIK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.44M sh
Reported value held$21.00M
Portfolio Weight1.23%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's ANIK position evolved

Caligan Partners LP first disclosed a stake in ANIK in Q3 2023 at 1,081,360 shares (US$20.1M). The position peaked in Q1 2024 at 1,435,993 shares, worth US$36.5M. Across 12 filings, Caligan Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 1,435,130 shares valued at US$21.0M. Notable position changes include a 33% increase in Q1 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.08M $20.15M New
Q4 2023 1.08M $24.50M Hold
Q1 2024 1.44M $36.47M Add
Q2 2024 1.44M $36.37M Hold
Q3 2024 1.44M $35.45M Hold
Q4 2024 1.44M $23.62M Hold
Q1 2025 1.44M $21.57M Hold
Q2 2025 1.44M $15.18M Hold
Q3 2025 1.44M $13.49M Hold
Q4 2025 1.44M $13.79M Hold
Q1 2026 1.44M $20.81M Hold
Q2 2026 1.44M $21.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIK and 13F data

ANIK (ANIKA THERAPEUTICS INC) is a Health Care company. 19 other funds we track also report a position in ANIK — the largest reported positions include CAPITAL MANAGEMENT CORP /VA (US$6.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIK

All ANIK fund holders →

FAQ

How long has Caligan Partners LP held ANIK?

Caligan Partners LP has disclosed ANIK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Caligan Partners LP's current position in ANIK?

As of Q2 2026, Caligan Partners LP holds 1.44M shares of ANIK (ANIKA THERAPEUTICS INC), valued at $21.00M, representing 1.23% of its reported portfolio and ranking #18.

Has Caligan Partners LP been buying or selling ANIK?

In the latest 13F filing (Q2 2026), Caligan Partners LP held unchanged its position in ANIK. The position peaked in Q1 2024 at 1.44M shares.

Which other funds hold ANIK?

Other major institutional holders of ANIK include CAPITAL MANAGEMENT CORP /VA, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.